Moreover, serum-containing MSJZD weakened EMT passage and AKT/GSK3β pathway activation and induced apoptosis-related markers in NSCLC cells triggered by TGF-β1. The gene discussed is GSK3B; the disease is non-small cell lung carcinoma.